Fast, lab-grade diagnostics, for healthier pets

LFAs are rapid immunodiagnostic tests that use antibody-antigen interactions on a test strip to detect specific pathogens or antibodies in a sample. They provide quick and reliable diagnostic results at the point of care without requiring complex lab equipment. LFAs are widely used in veterinary diagnostics for diseases affecting companion animals like dogs and cats.

The iaX from Assaya is a precision instrument that optimizes and automates the reading of LFA tests, providing rapid quantitative or qualitative results. It increases the accuracy and speed of diagnostics, facilitating early disease detection and treatment decisions in clinic settings.

LFAs are simple to use, provide results within minutes, require minimal sample preparation, and do not need specialized lab infrastructure. They allow veterinarians to diagnose infections or conditions quickly on-site, improving clinical decision-making and patient outcomes.

Modern LFAs, including fluorescence-based ones, have sensitivity and specificity comparable to PCR in detecting pathogens such as canine distemper virus. They also enable direct testing from clinical samples like blood or swabs without nucleic acid purification, enhancing usability at the point of care.

LFAs can detect a wide range of infectious agents common in companion animals, such as canine distemper virus, parvovirus, feline viruses, and other pathogens relevant to urban pet populations. They can also identify antibodies for diseases, aiding in vaccination status evaluation and epidemiological monitoring.

LFAs require minimal training to perform and interpret, making them suitable for busy clinics. iaX analyzers further streamline workflow by automating tests and providing digital readouts. Both technologies reduce turnaround time compared to sending samples to external labs.

LFAs may have lower sensitivity for some pathogens than advanced lab methods and can produce false positives or negatives under certain conditions. It is important to validate LFA results with clinical signs and other diagnostic methods when needed. Optimizing sample handling and testing protocols enhances accuracy.

While there is an upfront cost for test kits and/or analyzers, rapid in-clinic diagnostics reduce the need for costly lab send-outs, accelerate treatment decisions, and improve patient care efficiency, making them economically attractive for urban veterinary practices.

Yes, LFAs and iaX tests can be used for routine screening of infectious diseases in asymptomatic animals, helping in early detection, isolation, and control of contagious diseases in multi-pet urban environments.

Veterinarians should procure test kits and analyzers from reputable suppliers with validated veterinary diagnostic products. Consulting with veterinary diagnostic companies specializing in LFA development and immunoassay technology ensures quality and support.